Medicare Industry Update - New Alzheimer’s Drug Aduhelm
CMS Proposes Medicare Coverage Policy for Aduhelm for the treatment of Alzheimer’s Disease; which means the FDA-approved drug will be covered for people with Medicare, but only if they are enrolled in qualifying clinical trials.
Have questions about Aduhelm or how Medicare premiums could be affected? Call us at 800-268-2800.
The Agent Marketing Portfolio (AMP) catalog is an exclusive offer to contracted agents.
Order your custom personalized marketing pieces today!